Efectos secundarios del tratamiento para la leucemia linfoblástica aguda .. ( PEG-L asparaginasa; Oncaspar®) administrada por inyección. O Vincristina. L-asparaginase, definition: alkylating anticancer drug used in the treatment of L -asparaginasa, definition: fármaco alquilante antineoplásico, utilizado para el Los efectos secundarios más comunes son nauseas, vómitos. y otros efectos adversos de este grupo de fármacos, ya que estos pacientes los efectos citotóxicos de la quimioterapia son mediados por diversos . Actinomicina D, metotrexato, andrógenos, L-asparaginasa, procarbazina, vincristina.
|Published (Last):||16 July 2011|
|PDF File Size:||10.39 Mb|
|ePub File Size:||18.26 Mb|
|Price:||Free* [*Free Regsitration Required]|
How to search [pdf].
Title of the trial for lay people, in easily understood, i. Subjects must have fully recovered from the acute toxic effects of all previous chemotherapy, immunotherapy, or radiotherapy treatment before enrollment.
Known allergy to Captisol a cyclodextrin derivative used to solubilize carfilzomib; for a complete listing of Captisol-enabled drugs, see the Ligand Pharmaceuticals, Inc. Son aptos los sujetos que hayan sufrido una alergia previa a la asparaginasa PEG pero que puedan recibir Erwinia.
Positive culture for bacteria or fungus within 14 days of the initiation of therapy 7. Trials with results Trials without results.
IMP with orphan designation in the indication. Clinical trials The European Union Clinical Trials Register allows you to search for protocol and results information on: Karnofsky or Lansky scores? Definition of the end of the trial and justification where it is not the last visit of the last subject undergoing the trial. Date on which this record was first entered in the EudraCT database:. Trials with results Trials without results Clear advanced search filters.
Age 18 years or younger at the time of study treatment initiation. Time to toxicity will be evaluated to differentiate single-agent carfilzomib from carfilzomib in l-saparaginasa with induction chemotherapy? Subjects who have had a previous allergy to PEG-asparaginase but can receive Erwinia are eligible. Subjects must have a serum creatinine level that is?
Cancer AND drug name. Los sujetos deben haber finalizado todo tipo de inmunoterapia activa p.
Both Female Only Male Only. Clear advanced search filters.
The IMP has been designated in this indication as an orphan drug in the Community. Subjects are under 18 years old.
Weight Management Health Library, Free Bariatric Surgery Videos, Learn About Food, Nutrion, Diet
Plans for treatment or care after the subject has ended the participation in the trial if it is different from the expected normal treatment of that condition. Phase 1b – To assess the safety and tolerability of carfilzomib, alone and in combination with induction chemotherapy, for the treatment of children with relapsed or refractory acute lymphoblastic leukemia ALL -To determine the maximum tolerated dose MTD of carfilzomib in combination with induction chemotherapy.
The duration of this interval must be approved by the Onyx study medical monitor. Adequate liver function, defined as both of the following: Known allergy to any of the drugs used in the study. Review by the Competent Authority or Ethics Committee in the country concerned. The trial involves single site in the Member State concerned.
Combination product that includes a device, but does not involve an Advanced Therapy. Committee on Advanced therapies CAT has issued a classification for this product. Active treatment for graft-versus-host disease 6.
EU Clinical Trials Register. Pneumonia AND sponsor name. For agents that have known adverse events occurring beyond 7 days after administration, this period must be extended beyond the time during which adverse events are known to occur. For these items you should use the filters and not add them to your efecctos terms in the text field.
A group of cancers that usually begins in the bone marrow and results in high numbers of abnormal white blood cells. Restricciones de tratamientos previos: Relapsed or Refractory Acute Lymphoblastic Leukemia.